Every 340B program eventually hits the same wall. Sites multiply, transaction volume climbs, and drug spend rises, but the manual, periodic way most teams manage inventory, workflow, and cost stays the same. That mismatch shows up on both sides of the program at once.
Teams are now often stocking medications across 21 or more locations, straining the manual, per-site counts most programs still rely on. In that same audit cycle, 49% of audited entities received an adverse HRSA finding, largely because the registries and billing records behind those transactions hadn’t kept pace with that growth.
Audit risk, cost leakage, and workflow strain show up as three separate line items, but trace back to one operational gap.Â
340B Inventory Management Has Outgrown Manual, Per-Site Tracking
Contract pharmacy participation grew from under 1% of U.S. pharmacies in 2010 to over 40% by 2022, a national pattern that shows up well beyond any single health system. Inventory now spans retail, specialty, and ambulatory clinic settings that most teams never had to account for a decade ago, and most teams report no real visibility into exactly those categories.
Split-billing and accumulator tracking make 340B inventory management harder to trust. A drug can look compliant in a wholesaler’s system and be flagged in an EHR export, because the two don’t talk to each other automatically.
Most teams build their tracking for two or three sites, so it doesn’t scale linearly. Simply adding another dashboard doesn’t fix that structural mismatch. The underlying process has to change instead.
What actually closes the gap is a single daily view across every site instead of a per-location manual count. That’s only feasible without adding headcount if AI-assisted analysis is pulling and reconciling data from every site automatically, rather than a person checking each location by hand.
Where Pharmacy Workflow Optimization Breaks Down
Inventory shows where the gap lives. Workflow shows why it exists. Reconciling a single 340B transaction means pulling data from four separate systems by hand:
- TPA claims data
- EHR records
- Wholesaler purchase history
- Dispensing cabinet logs
Manual reconciliation has become the default operating model at most covered entities, and it’s landing on already-stretched pharmacy technicians who increasingly take on 340B and compliance duties on top of their existing dispensing workload. Teams split documentation and task tracking, covering who reviewed what, when, and what happened next, across spreadsheets, email threads, and whatever system each person happens to prefer.
Reconciling by hand costs teams the hours they need for the exceptions that actually matter, such as the transactions that would surface a real compliance issue or a real savings opportunity.
The Cost Control Blind Spot in 340B Program Management
The same scale-versus-process gap shows up on the financial side. Drug spend continues to outpace health system margins, and most cost review still happens in occasional, ad hoc pushes rather than on a fixed cadence. Health systems increasingly judge 340B program management on margin, not just compliance standing, which changes who in the organization pays attention to it.
Sentara eliminated over $3.45 million in drug spend by moving to a 30-minute weekly review cadence per hospital, not by hiring more staff or running quarterly deep dives. Reviewing more often, in smaller doses, produced that result.
AI-assisted analysis is what compresses a task that used to take hours into the 30 minutes Sentara’s teams actually spent. That same shift, continuous review replacing periodic review, applies just as directly to inventory and workflow.
| Factor | Periodic model | Continuous model |
| Inventory | Per-site manual counts | One daily cross-site view |
| Workflow | Manual line-by-line reconciliation | Exception-based review |
| Cost | Ad hoc or quarterly spend review | 30-minute weekly review |
How Inventory and Workflow Gaps Become Audit Risk
Audit findings are what happen when weak 340B inventory management and workflow gaps go unaddressed long enough for HRSA to find them.
OPAIS Is Where the Gap Surfaces First
Incorrect OPAIS records account for roughly three-quarters of adverse findings. The most common issues are specific and recurring:
- Closed contract pharmacies still listed in the registry
- Duplicate registrations for the same site
- Entity data that hasn’t changed since the last leadership transition
Medicaid Exclusion File mismatches, the second most common finding, usually trace back to a billing practice that changed internally without a matching OPAIS update.
Both findings point to recordkeeping that fell behind daily operations, exactly the kind of gap a well-run program can still trigger. HRSA still treats an inaccurate registry as a finding in itself, because the registry is what the agency uses to validate every transaction underneath it.
A Corrective Action Plan Doesn’t Fix a Process Gap
Roughly 68% of re-audited entities remained non-compliant, meaning most covered entities file a corrective action plan without fixing the underlying process that caused it. Filing paperwork closes the specific finding, but the process that produced it keeps running until the team actually rebuilds it. Closing the gap means changing how often, and how thoroughly, the team reviews each transaction, not just documenting that a review happened once.
AI-assisted analysis reviewing every transaction on an ongoing basis, instead of a quarterly or annual sample, catches and corrects the same registry and billing gaps before an auditor ever goes looking for them.
Bringing Inventory, Workflow, and Cost Into One System
Inventory, workflow, and cost all break down for the same reason, a scale that has outgrown periodic, manual review. One continuous system fixes all three, replacing the three separate periodic ones that exist today. Modern 340B program management treats inventory, workflow, and cost as one connected system, not three separate departments running three separate spreadsheets.
Fragmented Tools Are Why the Gap Persists
Fragmented tools created that gap. A separate system handles tracking, a separate one handles compliance, a separate one handles spend, and none of them talk to each other.
The proposed 340B Rebate Model adds a fourth data demand on top of the existing three, since purchase decisions, rebate eligibility, and payment tracking all need to reconcile with the same underlying transaction data. 66.7% of 340B leaders already name the rebate transition as their top concern, a sign the gap is widening faster than most programs can staff around.
One Continuous System Replaces Three
Continuous, system-wide tracking replaces the annual or reactive review cycle across all three pillars at once. Inventory, workflow, and cost stop being three separate problems and become three views into the same data.
AI-assisted analysis does the constant, cross-system reconciliation a person can’t do by hand at this scale. That frees a team’s time for the exceptions and decisions that actually need a person, rather than the manual pulling and matching that used to consume it.
Bluesight built 340BCheck around that shift. It connects 340B inventory management, workflow, and compliance data into one continuously audit-ready system, replacing three separate periodic checks.
See 340BCheck in action and request a demo.